Novo Nordisk has launched its hugely popular weight-loss drug Wegovy in Thailand, an executive of the Danish drugmaker's local subsidiary said on Monday, marking the injectable drug's first entry into the Southeast Asian market.

Novo Nordisk (NVO) has launched its weight-loss drug Wegovy in Thailand, Reuters reported on Monday, citing an executive of the drugmaker’s Thai subsidiary. The launch in Thailand marks Wegovy’s entry into the Southeast Asian market.

Novo Nordisk has launched its popular weight-loss drug Wegovy in Thailand, marking its first entry into the Southeast Asian market. The drug, seen as a game-changer, is part of Novo Nordisk's efforts to combat obesity,